Tag: cardiovascular devices industry

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Cardiovascular Devices Market CAGR Outlook And Future Development

The cardiovascular devices market has experienced robust expansion in recent years. Its size is projected to increase from $72.22 billion in 2025 to $76.6 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.1%. Historically, this growth has stemmed from factors such as the increasing incidence of cardiovascular diseases, the wider adoption of interventional cardiology procedures, advancements in surgical methods, the expanding infrastructure for cardiac care, and the greater deployment of implantable cardiac devices.

The cardiovascular devices market size is anticipated to experience robust growth over the next few years. This market is projected to expand to $100.37 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. This forecasted growth is attributable to several factors, including the escalating demand for structural heart interventions, the increasing adoption of AI-assisted cardiac diagnostics, the expansion of outpatient cardiovascular procedures, growing investments in next-generation cardiovascular devices, and continuous innovation in biocompatible and smart materials. Significant trends during the forecast period encompass the increasing integration of minimally invasive cardiovascular devices, the rising utilization of transcatheter therapies, the growing incorporation of advanced imaging-guided interventions, the expansion of remote cardiac monitoring solutions, and an enhanced focus on device miniaturization and precision.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=18414392&type=smp&name=Cardiovascular%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Cardiovascular Devices Market Demand Drivers Opening New Revenue Streams

The expanding occurrence of cardiovascular conditions is projected to fuel the expansion of the cardiovascular device market in the future. These disorders are defined as a range of health issues impacting the heart and blood vessels, covering diverse ailments and conditions of the circulatory system. This increasing occurrence stems from factors like an aging demographic, inactive routines, inadequate nutrition, and an escalation in conditions like high blood pressure and diabetes. The cardiovascular device market facilitates this development by providing instruments that aid heart performance and blood circulation for individuals with compromised or failing hearts. For example, data from January 2024, released by the American Heart Association, a US-based non-profit organization, indicated that the age-adjusted death rate attributed to cardiovascular disease rose to 233.3 per 100,000 in 2024, marking an increase of 4.0% from 224.4 per 100,000 in 2023. Consequently, the heightened prevalence of cardiovascular disorders is propelling the growth of the cardiovascular device market.

Cardiovascular Devices Market Segment Landscape: Which Areas Lead Development?

The cardiovascular devices market covered in this report is segmented –

1) By Type: Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment

2) By Type of Expenditure: Public, Private

3) By End User: Hospitals And Clinics, Cardiac Care Centers And Specialty Clinics, Other End Users

Subsegments:

1) By Cardiovascular Surgery Devices And Equipment: Coronary Artery Bypass Graft (CABG) Equipment, Heart Valve Repair And Replacement Devices, Aortic Aneurysm Repair Devices, Cardiopulmonary Bypass Equipment, Other Cardiovascular Surgery Devices

2) By Cardiac Rhythm Management (CRM) Devices And Equipment: Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) Devices

3) By Interventional Cardiology Devices And Equipment: Stents (Drug-Eluting, Bare-Metal), Catheters (Balloon, Diagnostic, Guiding), Angioplasty Equipment, Guidewires, Other Interventional Cardiology Devices

4) By Defibrillator Devices And Equipment: Implantable Cardioverter Defibrillators (ICDs), Automated External Defibrillators (AEDs), Wearable Defibrillators, External Defibrillators

5) By Peripheral Vascular Devices And Equipment: Peripheral Stents, Balloons (Peripheral Angioplasty), Embolic Protection Devices, Endovenous Laser Devices, Other Peripheral Vascular Devices

6) By Prosthetic Heart Valve Devices And Equipment: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves (TAVR), Other Prosthetic Heart Valve Devices

7) By Electrophysiology Devices And Equipment: Ablation Catheters, Electrophysiology Mapping Systems, ECG And EKG Systems, Cardiac Mapping And Navigation Systems, Other Electrophysiology Devices

8) By Cardiac Assist Devices And Equipment: Ventricular Assist Devices (LVADs), Intra-Aortic Balloon Pumps, Total Artificial Heart, Extracorporeal Membrane Oxygenation (ECMO), Other Cardiac Assist Devices

Cardiovascular Devices Market Trends Powering Strategic Industry Growth

Leading companies within the cardiovascular devices market are dedicating efforts to developing advanced interventional solutions, such as drug-coated balloon catheters, to effectively treat challenging coronary conditions and enhance long-term patient outcomes. A drug-coated balloon catheter serves as a minimally invasive instrument that both dilates a constricted coronary artery segment and simultaneously delivers an antiproliferative drug, for example, paclitaxel, to the arterial wall, thus aiding in the prevention of restenosis without implanting a permanent scaffold. For instance, in March 2024, Boston Scientific, a US-based medical device manufacturer, obtained U.S. FDA approval for its Agent drug-coated balloon catheter, which is the first device of its kind sanctioned for treating coronary in-stent restenosis (ISR). This device demonstrated significant effectiveness in mitigating the recurrence of vessel narrowing during a study involving 480 patients, providing interventional cardiologists with a non-stent alternative for ISR management.

Cardiovascular Devices Market Top Companies Driving Competitive Growth

Major companies operating in the cardiovascular devices market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, Johnson & Johnson, Terumo Corporation, Getinge AB, Teleflex Incorporated, Becton Dickinson and Company, Siemens Healthineers AG, Fresenius SE & Co. KGaA, GE HealthCare Technologies Inc., Stryker Corporation, B. Braun Medical Pvt. Ltd., Baxter International Inc., Fujifilm Holdings Corporation, Canon Medical Systems Corporation, MicroPort Scientific America Inc., W. L. Gore & Associates Inc., AngioDynamics Inc., CryoLife Inc., Endologix LLC, Lombard Medical Limited, Avinger Inc., Abiomed Inc., Biosensors International Group Ltd., Biotronik SE & Co. KG, CeloNova BioSciences Inc., LeMaitre Vascular Inc.

View The Full Cardiovascular Devices Market Report:

https://thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Cardiovascular Devices Market Global Footprint: Which Region Leads The Industry?

North America was the largest region in the global cardiovascular devices market in 2025. Western Europe was the second largest region in the global cardiovascular devices market. Africa. was the smallest region in the global cardiovascular devices market. The regions covered in the cardiovascular devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Cardiovascular Devices Market During The Forecast Period?

The cardiovascular devices market has seen substantial growth in recent years. Its valuation is anticipated to rise from $72.22 billion in 2025 to $76.6 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. The expansion observed historically is attributable to the increasing occurrence of cardiovascular diseases, the broadening of interventional cardiology procedures, enhancements in surgical techniques, the expanding availability of cardiac care infrastructure, and the greater utilization of implantable cardiac devices.

The cardiovascular devices market is projected for significant expansion over the coming years, with its value anticipated to reach $100.37 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. This growth during the forecast period is driven by several factors, including the escalating demand for structural heart interventions, the increasing embrace of AI-assisted cardiac diagnostics, the expansion of cardiovascular procedures conducted in outpatient settings, rising investments in advanced cardiovascular devices, and ongoing advancements in biocompatible and smart materials. Notable trends during this period encompass the greater adoption of minimally invasive cardiovascular devices, the increasing application of transcatheter therapies, the broader integration of imaging-guided interventions, the proliferation of remote cardiac monitoring solutions, and an intensified focus on device miniaturization and precision.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=1972&type=smp

What Market Drivers Are Helping Shape The Cardiovascular Devices Market Expansion?

The expanding occurrence of cardiovascular conditions is projected to boost the expansion of the cardiovascular device market in the future. These disorders represent a category of health issues impacting the heart and blood vessels, encompassing diverse ailments of the circulatory system. This rising prevalence stems from factors like aging demographics, inactive lifestyles, inadequate nutrition, and an uptick in conditions such as hypertension and diabetes. The cardiovascular device market facilitates this progression by providing equipment designed to aid heart function and maintain blood flow for individuals with compromised cardiac health. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Consequently, the heightened occurrence of cardiovascular disorders is fueling the expansion of the cardiovascular device market.

How Is The Cardiovascular Devices Market Distributed Across Key Segments?

The cardiovascular devices market covered in this report is segmented –

1) By Type: Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment

2) By Type of Expenditure: Public, Private

3) By End User: Hospitals And Clinics, Cardiac Care Centers And Specialty Clinics, Other End Users

Subsegments:

1) By Cardiovascular Surgery Devices And Equipment: Coronary Artery Bypass Graft (CABG) Equipment, Heart Valve Repair And Replacement Devices, Aortic Aneurysm Repair Devices, Cardiopulmonary Bypass Equipment, Other Cardiovascular Surgery Devices

2) By Cardiac Rhythm Management (CRM) Devices And Equipment: Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) Devices

3) By Interventional Cardiology Devices And Equipment: Stents (Drug-Eluting, Bare-Metal), Catheters (Balloon, Diagnostic, Guiding), Angioplasty Equipment, Guidewires, Other Interventional Cardiology Devices

4) By Defibrillator Devices And Equipment: Implantable Cardioverter Defibrillators (ICDs), Automated External Defibrillators (AEDs), Wearable Defibrillators, External Defibrillators

5) By Peripheral Vascular Devices And Equipment: Peripheral Stents, Balloons (Peripheral Angioplasty), Embolic Protection Devices, Endovenous Laser Devices, Other Peripheral Vascular Devices

6) By Prosthetic Heart Valve Devices And Equipment: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves (TAVR), Other Prosthetic Heart Valve Devices

7) By Electrophysiology Devices And Equipment: Ablation Catheters, Electrophysiology Mapping Systems, ECG And EKG Systems, Cardiac Mapping And Navigation Systems, Other Electrophysiology Devices

8) By Cardiac Assist Devices And Equipment: Ventricular Assist Devices (LVADs), Intra-Aortic Balloon Pumps, Total Artificial Heart, Extracorporeal Membrane Oxygenation (ECMO), Other Cardiac Assist Devices

Which Trends Are Influencing The Direction Of The Cardiovascular Devices Market?

Leading companies within the cardiovascular devices market are concentrating on developing advanced interventional solutions, such as drug-coated balloon catheters, to address complex coronary conditions and enhance long-term patient outcomes. A drug-coated balloon catheter functions as a minimally invasive tool that dilates a narrowed coronary artery segment and simultaneously delivers an antiproliferative drug (e.g., paclitaxel) to the arterial wall, thereby helping to prevent restenosis without leaving behind a permanent scaffold. For instance, in March 2024, Boston Scientific, a US-based medical device company, secured U.S. FDA approval for its Agent drug-coated balloon catheter, marking the first of its kind for treating coronary in-stent restenosis (ISR). This device exhibited substantial efficacy in reducing the recurrence of vessel narrowing in a study involving 480 patients and presents interventional cardiologists with a non-stent alternative for ISR management.

Which Companies Form The Competitive Landscape Of The Cardiovascular Devices Market?

Major companies operating in the cardiovascular devices market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, Johnson & Johnson, Terumo Corporation, Getinge AB, Teleflex Incorporated, Becton Dickinson and Company, Siemens Healthineers AG, Fresenius SE & Co. KGaA, GE HealthCare Technologies Inc., Stryker Corporation, B. Braun Medical Pvt. Ltd., Baxter International Inc., Fujifilm Holdings Corporation, Canon Medical Systems Corporation, MicroPort Scientific America Inc., W. L. Gore & Associates Inc., AngioDynamics Inc., CryoLife Inc., Endologix LLC, Lombard Medical Limited, Avinger Inc., Abiomed Inc., Biosensors International Group Ltd., Biotronik SE & Co. KG, CeloNova BioSciences Inc., LeMaitre Vascular Inc.

Access The Complete Cardiovascular Devices Market Report:

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Which Region Contributes The Most To The Cardiovascular Devices Market?

North America was the largest region in the global cardiovascular devices market in 2025. Western Europe was the second largest region in the global cardiovascular devices market. Africa. was the smallest region in the global cardiovascular devices market. The regions covered in the cardiovascular devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Cardiovascular Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=1972&type=smp

Browse Through More Reports Similar to the Global Cardiovascular Devices Market 2026, By The Business Research Company

Stress Tests Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/stress-tests-equipment-global-market-report

Cardiac Biomarkers Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Remote Cardiac Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/remote-cardiac-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Cardiovascular Devices Market Between 2026 And 2030?

The cardiovascular devices market has experienced robust expansion in recent years. It is anticipated to grow from $72.22 billion in 2025 to $76.6 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.1%. Historically, this growth can be attributed to the increasing prevalence of cardiovascular diseases, the expansion of interventional cardiology procedures, improvements in surgical techniques, the growing availability of cardiac care infrastructure, and the increased use of implantable cardiac devices.

The market for cardiovascular devices is anticipated to experience robust expansion over the coming years. This market is projected to reach a valuation of $100.37 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. This projected growth during the forecast period is attributable to several factors, including the escalating demand for structural heart interventions, the increasing uptake of AI-assisted cardiac diagnostics, the expansion of outpatient cardiovascular procedures, rising investments in next-generation cardiovascular devices, and ongoing innovation in biocompatible and smart materials. Key trends characterizing this forecast period encompass the increasing adoption of minimally invasive cardiovascular devices, a rise in the application of transcatheter therapies, the growing integration of advanced imaging-guided interventions, the expansion of remote cardiac monitoring solutions, and an intensified focus on device miniaturization and precision.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=1972&type=smp

What Key Factors Are Shaping The Cardiovascular Devices Market Landscape?

The expanding occurrence of cardiovascular disorders is anticipated to fuel the growth of the cardiovascular device market in the coming years. These disorders encompass a range of medical conditions affecting the heart and blood vessels, including various diseases impacting the circulatory system. The escalating prevalence can be attributed to an aging global population, inactive lifestyles, unhealthy eating habits, and an increase in conditions such as hypertension and diabetes. The cardiovascular device market addresses this trend by offering devices that assist heart function and blood flow for individuals with compromised or failing hearts. For instance, in January 2024, the American Heart Association, a US-based non-profit organization, reported that the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, representing a 4.0% increase from 224.4 per 100,000 in 2023. Consequently, the rising prevalence of cardiovascular disorders is a significant factor driving the expansion of the cardiovascular device market.

What Are The Key Segment Divisions In The Cardiovascular Devices Market Segment Structure?

The cardiovascular devices market covered in this report is segmented –

1) By Type: Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment

2) By Type of Expenditure: Public, Private

3) By End User: Hospitals And Clinics, Cardiac Care Centers And Specialty Clinics, Other End Users

Subsegments:

1) By Cardiovascular Surgery Devices And Equipment: Coronary Artery Bypass Graft (CABG) Equipment, Heart Valve Repair And Replacement Devices, Aortic Aneurysm Repair Devices, Cardiopulmonary Bypass Equipment, Other Cardiovascular Surgery Devices

2) By Cardiac Rhythm Management (CRM) Devices And Equipment: Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) Devices

3) By Interventional Cardiology Devices And Equipment: Stents (Drug-Eluting, Bare-Metal), Catheters (Balloon, Diagnostic, Guiding), Angioplasty Equipment, Guidewires, Other Interventional Cardiology Devices

4) By Defibrillator Devices And Equipment: Implantable Cardioverter Defibrillators (ICDs), Automated External Defibrillators (AEDs), Wearable Defibrillators, External Defibrillators

5) By Peripheral Vascular Devices And Equipment: Peripheral Stents, Balloons (Peripheral Angioplasty), Embolic Protection Devices, Endovenous Laser Devices, Other Peripheral Vascular Devices

6) By Prosthetic Heart Valve Devices And Equipment: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves (TAVR), Other Prosthetic Heart Valve Devices

7) By Electrophysiology Devices And Equipment: Ablation Catheters, Electrophysiology Mapping Systems, ECG And EKG Systems, Cardiac Mapping And Navigation Systems, Other Electrophysiology Devices

8) By Cardiac Assist Devices And Equipment: Ventricular Assist Devices (LVADs), Intra-Aortic Balloon Pumps, Total Artificial Heart, Extracorporeal Membrane Oxygenation (ECMO), Other Cardiac Assist Devices

What Market Trends Are Affecting The Cardiovascular Devices Market?

Companies within the cardiovascular devices market are increasingly focused on developing advanced interventional solutions, such as drug-coated balloon catheters, to address challenging coronary conditions and enhance long-term patient outcomes. A drug-coated balloon catheter represents a minimally invasive tool designed to dilate a narrowed coronary artery segment while simultaneously delivering an antiproliferative drug (e.g., paclitaxel) to the arterial wall, effectively preventing restenosis without implanting a permanent scaffold. For example, in March 2024, Boston Scientific, a US-based medical device company, obtained U.S. FDA approval for its Agent drug-coated balloon catheter, which is the first of its kind specifically for treating coronary in-stent restenosis (ISR). This device proved highly effective in reducing the recurrence of vessel narrowing in a study involving 480 patients, thereby offering interventional cardiologists a non-stent alternative for managing ISR.

Which Organizations Are Engaged In The Cardiovascular Devices Market?

Major companies operating in the cardiovascular devices market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, Johnson & Johnson, Terumo Corporation, Getinge AB, Teleflex Incorporated, Becton Dickinson and Company, Siemens Healthineers AG, Fresenius SE & Co. KGaA, GE HealthCare Technologies Inc., Stryker Corporation, B. Braun Medical Pvt. Ltd., Baxter International Inc., Fujifilm Holdings Corporation, Canon Medical Systems Corporation, MicroPort Scientific America Inc., W. L. Gore & Associates Inc., AngioDynamics Inc., CryoLife Inc., Endologix LLC, Lombard Medical Limited, Avinger Inc., Abiomed Inc., Biosensors International Group Ltd., Biotronik SE & Co. KG, CeloNova BioSciences Inc., LeMaitre Vascular Inc.

Get The Full Cardiovascular Devices Market Report:

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Which Region Accounts For The Largest Portion Of The Cardiovascular Devices Market?

North America was the largest region in the global cardiovascular devices market in 2025. Western Europe was the second largest region in the global cardiovascular devices market. Africa. was the smallest region in the global cardiovascular devices market. The regions covered in the cardiovascular devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cardiovascular Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=1972&type=smp

Browse Through More Reports Similar to the Global Cardiovascular Devices Market 2026, By The Business Research Company

Stress Tests Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/stress-tests-equipment-global-market-report

Cardiac Biomarkers Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Remote Cardiac Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/remote-cardiac-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Cardiovascular Devices Market At The End Of The 2026–2030 Forecast Period?

The cardiovascular devices market has experienced robust growth in recent years. Projections indicate it will expand from $72.22 billion in 2025 to $76.6 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. This historical expansion can be attributed to factors such as the increasing prevalence of cardiovascular diseases, the growth in interventional cardiology procedures, improvements in surgical techniques, the expanding availability of cardiac care infrastructure, and the greater adoption of implantable cardiac devices.

The cardiovascular devices market is anticipated to experience substantial growth in the upcoming years. Its valuation is set to increase to $100.37 billion in 2030, progressing at a compound annual growth rate (CAGR) of 7.0%. This projected expansion over the forecast period is fueled by several factors, including an escalating demand for structural heart interventions, the increasing integration of AI-assisted cardiac diagnostics, the growth of outpatient cardiovascular procedures, rising investments in advanced cardiovascular devices, and ongoing innovations in biocompatible and smart materials. Significant developments expected during this forecast timeframe encompass the wider adoption of minimally invasive cardiovascular devices, the growing utilization of transcatheter therapies, an enhanced incorporation of sophisticated imaging-guided interventions, the broader availability of remote cardiac monitoring solutions, and a heightened emphasis on device miniaturization and precision.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=1972&type=smp

What Primary Drivers Are Shaping The Development Of The Cardiovascular Devices Market?

The projected expansion of the **cardiovascular device market** is largely attributable to the increasing incidence of **cardiovascular disorders**. These medical conditions, which affect the heart and blood vessels and encompass various circulatory system ailments, are becoming more common due to factors such as aging populations, sedentary lifestyles, poor dietary habits, and a rise in conditions like hypertension and diabetes. The **cardiovascular device market** supports this development by providing equipment that aids heart function and blood flow in individuals with weakened or failing hearts. For example, data from **January 2024** released by the **American Heart Association**, a **US** non-profit organization, indicated that the age-adjusted death rate from cardiovascular disease escalated to **233.3 per 100,000 in 2024**, an increase of **4.0%** from **224.4 per 100,000 in 2023**. This illustrates how the growing prevalence of **cardiovascular disorders** is indeed propelling the growth of the **cardiovascular device market**. The rising healthcare expenditure is anticipated to fuel the growth of the **cardiovascular device market** moving forward. Healthcare expenditure represents the total financial resources allocated to healthcare services by governments, businesses, and individuals, covering medical treatments, hospital care, medications, and public health initiatives. The increasing need for healthcare spending stems from the rising prevalence of chronic diseases, which require extensive and costly long-term treatments. Higher healthcare expenditure significantly boosts the **cardiovascular device market** by facilitating greater adoption of advanced treatment technologies and improving access to vital cardiac procedures. It also contributes to better hospital infrastructure, earlier diagnoses, and enhanced patient care, thereby driving increased utilization of innovative cardiovascular solutions. For instance, in **May 2024**, the **Office for National Statistics**, a **UK** government department, reported that total healthcare expenditure saw a **5.6%** increase in nominal terms in **2023**, reflecting a **0.9%** growth compared to **2022**. Consequently, the escalating healthcare expenditure is a significant driver for the growth of the **cardiovascular device market**.

What Segment Types Make Up The Cardiovascular Devices Market?

The cardiovascular devices market covered in this report is segmented –

1) By Type: Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment

2) By Type of Expenditure: Public, Private

3) By End User: Hospitals And Clinics, Cardiac Care Centers And Specialty Clinics, Other End Users

Subsegments:

1) By Cardiovascular Surgery Devices And Equipment: Coronary Artery Bypass Graft (CABG) Equipment, Heart Valve Repair And Replacement Devices, Aortic Aneurysm Repair Devices, Cardiopulmonary Bypass Equipment, Other Cardiovascular Surgery Devices

2) By Cardiac Rhythm Management (CRM) Devices And Equipment: Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) Devices

3) By Interventional Cardiology Devices And Equipment: Stents (Drug-Eluting, Bare-Metal), Catheters (Balloon, Diagnostic, Guiding), Angioplasty Equipment, Guidewires, Other Interventional Cardiology Devices

4) By Defibrillator Devices And Equipment: Implantable Cardioverter Defibrillators (ICDs), Automated External Defibrillators (AEDs), Wearable Defibrillators, External Defibrillators

5) By Peripheral Vascular Devices And Equipment: Peripheral Stents, Balloons (Peripheral Angioplasty), Embolic Protection Devices, Endovenous Laser Devices, Other Peripheral Vascular Devices

6) By Prosthetic Heart Valve Devices And Equipment: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves (TAVR), Other Prosthetic Heart Valve Devices

7) By Electrophysiology Devices And Equipment: Ablation Catheters, Electrophysiology Mapping Systems, ECG And EKG Systems, Cardiac Mapping And Navigation Systems, Other Electrophysiology Devices

8) By Cardiac Assist Devices And Equipment: Ventricular Assist Devices (LVADs), Intra-Aortic Balloon Pumps, Total Artificial Heart, Extracorporeal Membrane Oxygenation (ECMO), Other Cardiac Assist Devices

Which Market Trends Are Creating New Opportunities In The Cardiovascular Devices Market?

Leading companies within the cardiovascular devices market are prioritizing the development of advanced interventional solutions, such as drug-coated balloon catheters, to manage challenging coronary conditions and enhance patient outcomes over time. A drug-coated balloon catheter serves as a minimally invasive tool designed to dilate a narrowed coronary artery segment while simultaneously delivering an antiproliferative drug (e.g., paclitaxel) to the arterial wall, which helps prevent restenosis without leaving behind a permanent scaffold. For instance, in March 2024, Boston Scientific, a US-based medical device company, obtained U.S. FDA approval for its Agent drug-coated balloon catheter, marking it as the first device of its type approved for treating coronary in-stent restenosis (ISR). This particular device demonstrated significant efficacy in reducing the recurrence of vessel narrowing in a study of 480 patients, thereby offering interventional cardiologists a non-stent alternative for ISR management.

Who Are The Key Players Driving Competition In The Cardiovascular Devices Market?

Major companies operating in the cardiovascular devices market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, Johnson & Johnson, Terumo Corporation, Getinge AB, Teleflex Incorporated, Becton Dickinson and Company, Siemens Healthineers AG, Fresenius SE & Co. KGaA, GE HealthCare Technologies Inc., Stryker Corporation, B. Braun Medical Pvt. Ltd., Baxter International Inc., Fujifilm Holdings Corporation, Canon Medical Systems Corporation, MicroPort Scientific America Inc., W. L. Gore & Associates Inc., AngioDynamics Inc., CryoLife Inc., Endologix LLC, Lombard Medical Limited, Avinger Inc., Abiomed Inc., Biosensors International Group Ltd., Biotronik SE & Co. KG, CeloNova BioSciences Inc., LeMaitre Vascular Inc.

Read the full cardiovascular devices market report here:

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

How Does The Cardiovascular Devices Market Perform Across Major Global Regions?

North America was the largest region in the global cardiovascular devices market in 2025. Western Europe was the second largest region in the global cardiovascular devices market. Africa. was the smallest region in the global cardiovascular devices market. The regions covered in the cardiovascular devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cardiovascular Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=1972&type=smp

Browse Through More Reports Similar to the Global Cardiovascular Devices Market 2026, By The Business Research Company

Stress Tests Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/stress-tests-equipment-global-market-report

Cardiac Biomarkers Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Remote Cardiac Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/remote-cardiac-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the surgical intelligent auxiliary navigation device market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Cardiovascular Devices Market between 2026 and 2030?

The cardiovascular devices market has experienced robust expansion in recent years. This market is projected to expand from $72.22 billion in 2025 to reach $76.6 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.1%. Historically, this growth can be attributed to factors such as the increasing prevalence of cardiovascular diseases, the broadening scope of interventional cardiology procedures, advancements in surgical methods, the expanding availability of cardiac care infrastructure, and a rise in the adoption of implantable cardiac devices.

The cardiovascular devices market is projected to experience substantial expansion over the upcoming years. It is anticipated to reach $100.37 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. This growth during the forecast period is attributable to several factors, including the escalating demand for structural heart interventions, the increasing embrace of AI-assisted cardiac diagnostics, the expansion of outpatient cardiovascular procedures, rising investments in next-generation cardiovascular devices, and ongoing innovation in biocompatible and smart materials. Key trends anticipated during this period encompass the growing adoption of minimally invasive cardiovascular devices, an increase in the use of transcatheter therapies, the expanding integration of advanced imaging-guided interventions, the broader availability of remote cardiac monitoring solutions, and an intensified focus on device miniaturization and precision.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=1972&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Cardiovascular Devices Market?

The expanding incidence of cardiovascular disorders is anticipated to fuel the expansion of the cardiovascular device market in the coming years. These disorders represent a collection of medical ailments impacting the heart and blood vessels, covering various conditions related to the circulatory system. The escalating prevalence of these conditions is largely attributed to aging demographics, inactive lifestyles, unhealthy diets, and a rise in health issues like hypertension and diabetes. In response, the cardiovascular device market provides equipment designed to aid heart function and blood circulation for individuals with compromised or failing hearts. For example, data released in January 2024 by the American Heart Association, a US-based non-profit organization, indicated that the age-adjusted mortality rate from cardiovascular disease climbed to 233.3 per 100,000 in 2024, representing a 4.0% increase from 224.4 per 100,000 in 2023. Consequently, the growing occurrence of cardiovascular disorders is a significant factor driving the growth of the cardiovascular device market.

What Segments Are Included Within The Cardiovascular Devices Market?

The cardiovascular devices market covered in this report is segmented –

1) By Type: Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment

2) By Type of Expenditure: Public, Private

3) By End User: Hospitals And Clinics, Cardiac Care Centers And Specialty Clinics, Other End Users

Subsegments:

1) By Cardiovascular Surgery Devices And Equipment: Coronary Artery Bypass Graft (CABG) Equipment, Heart Valve Repair And Replacement Devices, Aortic Aneurysm Repair Devices, Cardiopulmonary Bypass Equipment, Other Cardiovascular Surgery Devices

2) By Cardiac Rhythm Management (CRM) Devices And Equipment: Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) Devices

3) By Interventional Cardiology Devices And Equipment: Stents (Drug-Eluting, Bare-Metal), Catheters (Balloon, Diagnostic, Guiding), Angioplasty Equipment, Guidewires, Other Interventional Cardiology Devices

4) By Defibrillator Devices And Equipment: Implantable Cardioverter Defibrillators (ICDs), Automated External Defibrillators (AEDs), Wearable Defibrillators, External Defibrillators

5) By Peripheral Vascular Devices And Equipment: Peripheral Stents, Balloons (Peripheral Angioplasty), Embolic Protection Devices, Endovenous Laser Devices, Other Peripheral Vascular Devices

6) By Prosthetic Heart Valve Devices And Equipment: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves (TAVR), Other Prosthetic Heart Valve Devices

7) By Electrophysiology Devices And Equipment: Ablation Catheters, Electrophysiology Mapping Systems, ECG And EKG Systems, Cardiac Mapping And Navigation Systems, Other Electrophysiology Devices

8) By Cardiac Assist Devices And Equipment: Ventricular Assist Devices (LVADs), Intra-Aortic Balloon Pumps, Total Artificial Heart, Extracorporeal Membrane Oxygenation (ECMO), Other Cardiac Assist Devices

Which Trends Are Expected To Influence The Cardiovascular Devices Market In The Upcoming Years?

Key companies within the cardiovascular devices market are concentrating on creating advanced interventional solutions, such as drug-coated balloon catheters, to address complex coronary issues and enhance long-term outcomes. A drug-coated balloon catheter is a minimally invasive instrument that expands a narrowed coronary artery segment and concurrently delivers an antiproliferative drug (e.g., paclitaxel) to the arterial wall, thereby helping to prevent restenosis without leaving behind a permanent implant. For example, in March 2024, Boston Scientific, a US-based medical device firm, obtained U.S. FDA approval for its Agent drug-coated balloon catheter, which is the first of its kind for managing coronary in-stent restenosis (ISR). This device exhibited substantial effectiveness in decreasing the recurrence of vessel narrowing in research involving 480 patients and offers interventional cardiologists a non-stent option for ISR management.

Who Are The Major Companies Operating In The Cardiovascular Devices Market?

Major companies operating in the cardiovascular devices market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, Johnson & Johnson, Terumo Corporation, Getinge AB, Teleflex Incorporated, Becton Dickinson and Company, Siemens Healthineers AG, Fresenius SE & Co. KGaA, GE HealthCare Technologies Inc., Stryker Corporation, B. Braun Medical Pvt. Ltd., Baxter International Inc., Fujifilm Holdings Corporation, Canon Medical Systems Corporation, MicroPort Scientific America Inc., W. L. Gore & Associates Inc., AngioDynamics Inc., CryoLife Inc., Endologix LLC, Lombard Medical Limited, Avinger Inc., Abiomed Inc., Biosensors International Group Ltd., Biotronik SE & Co. KG, CeloNova BioSciences Inc., LeMaitre Vascular Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Cardiovascular Devices Market?

North America was the largest region in the global cardiovascular devices market in 2025. Western Europe was the second largest region in the global cardiovascular devices market. Africa. was the smallest region in the global cardiovascular devices market. The regions covered in the cardiovascular devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cardiovascular Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=1972&type=smp

Browse Through More Reports Similar to the Global Cardiovascular Devices Market 2026, By The Business Research Company

Stress Tests Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/stress-tests-equipment-global-market-report

Cardiac Biomarkers Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Remote Cardiac Monitoring Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/remote-cardiac-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the cardiovascular devices market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Cardiovascular Devices Market Size?

The cardiovascular devices market has shown strong growth in recent years. It is projected to increase from $67.89 billion in 2024 to $72.22 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.4%. Historically, this growth has been influenced by factors including lifestyle-related diseases, an aging population, minimally invasive procedures and implantable devices, healthcare access, and regulatory approvals.

The cardiovascular devices market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $93.49 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.7%. Key factors driving this expansion during the forecast period include the rise of personalized medicine, advancements in remote monitoring, the expansion of emerging markets, the integration of artificial intelligence (AI), and the adoption of value-based healthcare models. Prominent trends expected over the forecast period encompass wearable cardiovascular devices, an increase in minimally invasive interventions, the development of bioresorbable devices, the growing adoption of remote consultations and telesurgery, and a shift towards sustainable and eco-friendly devices.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=1972&type=smp

What Core Market Drivers Are Expanding The Cardiovascular Devices Industry?

The increasing occurrence of cardiovascular disorders fuels the expansion of the cardiovascular device market. These disorders encompass a range of medical conditions that impact the heart and blood vessels, covering various diseases and issues within the circulatory system. A cardiovascular device is engineered to support cardiac function and blood flow for individuals with weakened or failing hearts. For instance, in June 2023, according to the Immigration and Checkpoints Authority, a Singapore-based government agency, there were 6,884 deaths attributed to heart and hypertensive diseases in 2022. This represented an increase of 10.35% compared to the 6,238 deaths recorded in 2021. Therefore, the rising prevalence of cardiovascular disorders is expected to drive the growth of the cardiovascular device market.

What Segment Insights Are Highlighted In The Cardiovascular Devices Market Report?

The cardiovascular devicesmarket covered in this report is segmented –

1) By Type: Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment

2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

3) By Type of Expenditure: Public, Private

4) By Product: Instruments Or Equipment, Disposables

Subsegments:

1) By Cardiovascular Surgery Devices And Equipment: Coronary Artery Bypass Graft (CABG) Equipment, Heart Valve Repair And Replacement Devices, Aortic Aneurysm Repair Devices, Cardiopulmonary Bypass Equipment, Other Cardiovascular Surgery Devices

2) By Cardiac Rhythm Management (CRM) Devices And Equipment: Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) Devices

3) By Interventional Cardiology Devices And Equipment: Stents (Drug-Eluting, Bare-Metal), Catheters (Balloon, Diagnostic, Guiding), Angioplasty Equipment, Guidewires, Other Interventional Cardiology Devices

4) By Defibrillator Devices And Equipment: Implantable Cardioverter Defibrillators (ICDs), Automated External Defibrillators (AEDs), Wearable Defibrillators, External Defibrillators

5) By Peripheral Vascular Devices And Equipment: Peripheral Stents, Balloons (Peripheral Angioplasty), Embolic Protection Devices, Endovenous Laser Devices, Other Peripheral Vascular Devices

6) By Prosthetic Heart Valve Devices And Equipment: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves (TAVR), Other Prosthetic Heart Valve Devices

7) By Electrophysiology Devices And Equipment: Ablation Catheters, Electrophysiology Mapping Systems, ECG And EKG Systems, Cardiac Mapping And Navigation Systems, Other Electrophysiology Devices

8) By Cardiac Assist Devices And Equipment: Ventricular Assist Devices (LVADs), Intra-Aortic Balloon Pumps, Total Artificial Heart, Extracorporeal Membrane Oxygenation (ECMO), Other Cardiac Assist Devices

What Future-Focused Trends Are Anticipated In The Cardiovascular Devices Market?

Leading companies in the cardiovascular devices market are releasing new products, such as the balloon ablation catheter, to boost their profitability within the sector. The balloon ablation catheter stands as the pioneering radiofrequency balloon ablation catheter designed for catheter-based cardiac electrophysiological mapping, encompassing both the stimulation and recording of the atria. For example, in October 2022, Biosense Webster, a US-based firm focused on the diagnosis and treatment of heart rhythm disorders, introduced the HELIOSTAR Balloon Ablation Catheter. The HELIOSTAR Balloon Ablation Catheter integrates proprietary one-shot balloon technology, facilitating pulmonary vein isolation in just 12 seconds, complete with customized energy delivery and an embedded 3D mapping solution.

Which Firms Are Driving Innovation Within The Cardiovascular Devices Market?

Major companies operating in the cardiovascular devices market include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, Johnson & Johnson, Terumo Corporation, Getinge AB, Teleflex Incorporated, Becton, Dickinson and Company, Siemens Healthineers AG, Fresenius SE & Co. KGaA, GE HealthCare Technologie Inc., Stryker Corporation, B. Braun Medical Pvt. Ltd., Baxter International Inc., Danaher Corporation, Fujifilm Holdings Corporation, Canon Medical Systems Corporation, MicroPort Scientific America Inc., W L Gore & Associates Inc., AngioDynamics Inc., CryoLife Inc., Endologix LLC, Lombard Medical Limited, Avinger Inc., Abiomed Inc., Biosensors International Group Ltd., Biotronik SE and Co. KG, CeloNovaBioSciences Inc., LeMaitre Vascular Inc., Nano Therapeutics Pvt. Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

What Regional Trends Are Shaping Growth In The Cardiovascular Devices Market?

North America was the largest region in the global cardiovascular devices market in 2024. Western Europe was the second largest region in the global cardiovascular devices market. Africa. was the smallest region in the global cardiovascular devices market. The regions covered in the cardiovascular devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=1972&type=smp

Browse Through More Reports Similar to the Global Cardiovascular Devices Market 2025, By The Business Research Company

Thermal Interface Materials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/thermal-interface-materials-global-market-report

Thermal Transfer Label Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/thermal-transfer-label-global-market-report

Geothermal Electricity Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/geothermal-electricity-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Cardiovascular Devices Market Expected To Become By 2029 Compared With Its 2025 Level?

Presently, the market encompassing cardiovascular devices is experiencing robust expansion, projected to ascend from a valuation of $67.89 billion in 2024 to $72.22 billion by 2025, reflecting a compound annual growth rate (CAGR) of 6.4%; this upward trajectory during the past period is largely attributable to factors such as the prevalence of lifestyle-related ailments, the increasing demographic trend of aging populations, the rise in both minimally invasive surgical techniques and implanted medical apparatus, broader availability of healthcare services, and the facilitation provided by regulatory clearances.

Anticipation holds that the market for cardiovascular devices will experience robust expansion in the coming years, reaching a valuation of $93.49 billion by 2029, propelled by a compound annual growth rate (CAGR) of 6.7%; this upward trajectory during the projected timeframe is largely due to advancements such as tailored medical treatments, heightened focus on monitoring from afar, expansion in developing territories, the incorporation of artificial intelligence (AI), and a shift towards healthcare models centered on value, alongside significant industry developments including the rise of wearable cardiac equipment, procedures requiring less invasive techniques, implantable devices that naturally dissolve, telehealth consultations and remote surgical procedures, and a growing emphasis on environmentally sound and green device options.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=1972&type=smp

Which Major Market Drivers Are Shaping The Future Of The Cardiovascular Devices Market?

The rising incidence of ailments affecting the heart and blood vessels, broadly termed cardiovascular disorders, is fueling expansion within the cardiovascular device sector. These conditions represent a range of medical problems impacting the circulatory system. Cardiovascular devices are instruments employed to maintain or assist the function of the heart and ensure adequate blood flow for individuals experiencing weakened or compromised cardiac function. For example, data released by the Immigration and Checkpoints Authority, an entity based in Singapore, revealed that in 2022, fatalities linked to hypertensive and heart conditions reached 6,884, signifying a rise of 10.35 percent over the 6,238 such deaths documented in 2021. Consequently, this growing burden of cardiovascular diseases is anticipated to act as a significant impetus for market expansion in cardiovascular devices.

How Is The Cardiovascular Devices Market Segmented?

The cardiovascular devicesmarket covered in this report is segmented –

1) By Type: Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment

2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

3) By Type of Expenditure: Public, Private

4) By Product: Instruments Or Equipment, Disposables

Subsegments:

1) By Cardiovascular Surgery Devices And Equipment: Coronary Artery Bypass Graft (CABG) Equipment, Heart Valve Repair And Replacement Devices, Aortic Aneurysm Repair Devices, Cardiopulmonary Bypass Equipment, Other Cardiovascular Surgery Devices

2) By Cardiac Rhythm Management (CRM) Devices And Equipment: Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) Devices

3) By Interventional Cardiology Devices And Equipment: Stents (Drug-Eluting, Bare-Metal), Catheters (Balloon, Diagnostic, Guiding), Angioplasty Equipment, Guidewires, Other Interventional Cardiology Devices

4) By Defibrillator Devices And Equipment: Implantable Cardioverter Defibrillators (ICDs), Automated External Defibrillators (AEDs), Wearable Defibrillators, External Defibrillators

5) By Peripheral Vascular Devices And Equipment: Peripheral Stents, Balloons (Peripheral Angioplasty), Embolic Protection Devices, Endovenous Laser Devices, Other Peripheral Vascular Devices

6) By Prosthetic Heart Valve Devices And Equipment: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves (TAVR), Other Prosthetic Heart Valve Devices

7) By Electrophysiology Devices And Equipment: Ablation Catheters, Electrophysiology Mapping Systems, ECG And EKG Systems, Cardiac Mapping And Navigation Systems, Other Electrophysiology Devices

8) By Cardiac Assist Devices And Equipment: Ventricular Assist Devices (LVADs), Intra-Aortic Balloon Pumps, Total Artificial Heart, Extracorporeal Membrane Oxygenation (ECMO), Other Cardiac Assist Devices

How Are Emerging Market Trends Shaping The Cardiovascular Devices Industry Landscape?

To boost their financial gains within the cardiovascular devices sector, major industry players are introducing novel medical instruments, exemplified by the balloon ablation catheter. This specific device represents the very first radiofrequency balloon ablation catheter engineered for the purpose of cardiac electrophysiological mapping via catheter intervention, covering both the recording and stimulation processes within the atria. Illustrating this development, Biosense Webster, an American firm specializing in the identification and management of heart rhythm irregularities, released the HELIOSTAR Balloon Ablation Catheter in October 2022. The HELIOSTAR Balloon Ablation Catheter incorporates unique single-application balloon technology, enabling pulmonary vein isolation in a mere twelve seconds, complemented by customized energy transmission and an integrated three-dimensional mapping system.

Who Are The Key Multinational Companies Dominating The Cardiovascular Devices Market?

Major companies operating in the cardiovascular devices market include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, Johnson & Johnson, Terumo Corporation, Getinge AB, Teleflex Incorporated, Becton, Dickinson and Company, Siemens Healthineers AG, Fresenius SE & Co. KGaA, GE HealthCare Technologie Inc., Stryker Corporation, B. Braun Medical Pvt. Ltd., Baxter International Inc., Danaher Corporation, Fujifilm Holdings Corporation, Canon Medical Systems Corporation, MicroPort Scientific America Inc., W L Gore & Associates Inc., AngioDynamics Inc., CryoLife Inc., Endologix LLC, Lombard Medical Limited, Avinger Inc., Abiomed Inc., Biosensors International Group Ltd., Biotronik SE and Co. KG, CeloNovaBioSciences Inc., LeMaitre Vascular Inc., Nano Therapeutics Pvt. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Cardiovascular Devices Market?

North America was the largest region in the global cardiovascular devices market in 2024. Western Europe was the second largest region in the global cardiovascular devices market. Africa. was the smallest region in the global cardiovascular devices market. The regions covered in the cardiovascular devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Request A Customized Version Of The Cardiovascular Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=1972&type=smp

Browse Through More Reports Similar to the Global Cardiovascular Devices Market 2025, By The Business Research Company

Thermal Interface Materials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/thermal-interface-materials-global-market-report

Thermal Transfer Label Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/thermal-transfer-label-global-market-report

Geothermal Electricity Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/geothermal-electricity-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Cardiovascular Devices Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The market size for cardiovascular devices has seen substantial growth in the past few years. The market, which is currently valued at $67.89 billion in 2024, is expected to rise to $72.22 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.4%. The considerable growth in the previous period is due to factors such as lifestyle-related illnesses, an increasingly aging population, the popularity of minimally invasive procedures and implantable devices, access to healthcare, and regulatory approvals.

Expectations are high for the cardiovascular devices market in the coming years, with strong growth projected. The market is predicted to reach a value of $93.49 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.7%. This growth during the forecast period is linked to developments in personalized medicine, remote monitoring, growth in emerging markets, integration of artificial intelligence (AI), and value-based healthcare. The forecast period also indicates trends such as wearable cardiovascular devices, minimally invasive interventions, bioresorbable devices, remote consultations and telesurgery, along with sustainable and eco-friendly devices.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=1972&type=smp

Which Primay Drivers Are Accelerating Growth in the Cardiovascular Devices Market?

The cardiovascular device market’s growth is fueled in part by the rising incidents of cardiovascular disorders. These disorders pertain to collective medical conditions that impact the heart and blood vessels, including a range of diseases and conditions affecting the circulatory system. Cardiovascular devices are those used to sustain heart performance and blood circulation in individuals with weakened or failing hearts. For example, in June 2023, the Immigration and Checkpoints Authority, a Singapore-based government entity, reported 6,884 deaths resulting from heart and hypertensive diseases in 2022. This represented a 10.35% increase from the 6,238 deaths recorded in 2021. As such, the escalating frequency of cardiovascular disorders is anticipated to propel the expansion of the cardiovascular device market.

Which Primary Segments of the Cardiovascular Devices Market Are Driving Growth and Industry Transformations?

The cardiovascular devicesmarket covered in this report is segmented –

1) By Type: Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment

2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

3) By Type of Expenditure: Public, Private

4) By Product: Instruments Or Equipment, Disposables

Subsegments:

1) By Cardiovascular Surgery Devices And Equipment: Coronary Artery Bypass Graft (CABG) Equipment, Heart Valve Repair And Replacement Devices, Aortic Aneurysm Repair Devices, Cardiopulmonary Bypass Equipment, Other Cardiovascular Surgery Devices

2) By Cardiac Rhythm Management (CRM) Devices And Equipment: Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) Devices

3) By Interventional Cardiology Devices And Equipment: Stents (Drug-Eluting, Bare-Metal), Catheters (Balloon, Diagnostic, Guiding), Angioplasty Equipment, Guidewires, Other Interventional Cardiology Devices

4) By Defibrillator Devices And Equipment: Implantable Cardioverter Defibrillators (ICDs), Automated External Defibrillators (AEDs), Wearable Defibrillators, External Defibrillators

5) By Peripheral Vascular Devices And Equipment: Peripheral Stents, Balloons (Peripheral Angioplasty), Embolic Protection Devices, Endovenous Laser Devices, Other Peripheral Vascular Devices

6) By Prosthetic Heart Valve Devices And Equipment: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves (TAVR), Other Prosthetic Heart Valve Devices

7) By Electrophysiology Devices And Equipment: Ablation Catheters, Electrophysiology Mapping Systems, ECG And EKG Systems, Cardiac Mapping And Navigation Systems, Other Electrophysiology Devices

8) By Cardiac Assist Devices And Equipment: Ventricular Assist Devices (LVADs), Intra-Aortic Balloon Pumps, Total Artificial Heart, Extracorporeal Membrane Oxygenation (ECMO), Other Cardiac Assist Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=1972&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Cardiovascular Devices Market?# Market?

North America was the largest region in the global cardiovascular devices market in 2024. Western Europe was the second largest region in the global cardiovascular devices market. Africa. was the smallest region in the global cardiovascular devices market. The regions covered in the cardiovascular devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Which Technological Trends Are Reshaping the Cardiovascular Devices Industry Dynamics?

Prominent entities in the cardiovascular devices market are introducing new innovative products such as the balloon ablation catheter, to enhance their market profitability. In the realm of catheter-based cardiac electrophysiological mapping, including both stimulation and recording of the atria, the balloon ablation catheter stands out as the first radiofrequency of its kind. In this regard, Biosense Webster, a US-based firm specializing in the science of diagnosing and treating heart rhythm disorders, launched the HELIOSTAR Balloon Ablation Catheter in October 2022. This cutting-edge product comes with unique one-shot balloon technology that enables pulmonary vein isolation in a mere 12 seconds, accompanied by customised energy delivery and a consolidated 3D mapping solution.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

What Parameters Are Used to Define the Cardiovascular Devices Market?

Cardiovascular devices are used to monitor and control irregular heartbeats and heart rhythm disorders.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=1972

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Cardiovascular Devices Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The market size for cardiovascular devices has seen substantial growth in the past few years. The market, which is currently valued at $67.89 billion in 2024, is expected to rise to $72.22 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.4%. The considerable growth in the previous period is due to factors such as lifestyle-related illnesses, an increasingly aging population, the popularity of minimally invasive procedures and implantable devices, access to healthcare, and regulatory approvals.

Expectations are high for the cardiovascular devices market in the coming years, with strong growth projected. The market is predicted to reach a value of $93.49 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.7%. This growth during the forecast period is linked to developments in personalized medicine, remote monitoring, growth in emerging markets, integration of artificial intelligence (AI), and value-based healthcare. The forecast period also indicates trends such as wearable cardiovascular devices, minimally invasive interventions, bioresorbable devices, remote consultations and telesurgery, along with sustainable and eco-friendly devices.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=1972&type=smp

Which Primay Drivers Are Accelerating Growth in the Cardiovascular Devices Market?

The cardiovascular device market’s growth is fueled in part by the rising incidents of cardiovascular disorders. These disorders pertain to collective medical conditions that impact the heart and blood vessels, including a range of diseases and conditions affecting the circulatory system. Cardiovascular devices are those used to sustain heart performance and blood circulation in individuals with weakened or failing hearts. For example, in June 2023, the Immigration and Checkpoints Authority, a Singapore-based government entity, reported 6,884 deaths resulting from heart and hypertensive diseases in 2022. This represented a 10.35% increase from the 6,238 deaths recorded in 2021. As such, the escalating frequency of cardiovascular disorders is anticipated to propel the expansion of the cardiovascular device market.

Which Primary Segments of the Cardiovascular Devices Market Are Driving Growth and Industry Transformations?

The cardiovascular devicesmarket covered in this report is segmented –

1) By Type: Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment

2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

3) By Type of Expenditure: Public, Private

4) By Product: Instruments Or Equipment, Disposables

Subsegments:

1) By Cardiovascular Surgery Devices And Equipment: Coronary Artery Bypass Graft (CABG) Equipment, Heart Valve Repair And Replacement Devices, Aortic Aneurysm Repair Devices, Cardiopulmonary Bypass Equipment, Other Cardiovascular Surgery Devices

2) By Cardiac Rhythm Management (CRM) Devices And Equipment: Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) Devices

3) By Interventional Cardiology Devices And Equipment: Stents (Drug-Eluting, Bare-Metal), Catheters (Balloon, Diagnostic, Guiding), Angioplasty Equipment, Guidewires, Other Interventional Cardiology Devices

4) By Defibrillator Devices And Equipment: Implantable Cardioverter Defibrillators (ICDs), Automated External Defibrillators (AEDs), Wearable Defibrillators, External Defibrillators

5) By Peripheral Vascular Devices And Equipment: Peripheral Stents, Balloons (Peripheral Angioplasty), Embolic Protection Devices, Endovenous Laser Devices, Other Peripheral Vascular Devices

6) By Prosthetic Heart Valve Devices And Equipment: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves (TAVR), Other Prosthetic Heart Valve Devices

7) By Electrophysiology Devices And Equipment: Ablation Catheters, Electrophysiology Mapping Systems, ECG And EKG Systems, Cardiac Mapping And Navigation Systems, Other Electrophysiology Devices

8) By Cardiac Assist Devices And Equipment: Ventricular Assist Devices (LVADs), Intra-Aortic Balloon Pumps, Total Artificial Heart, Extracorporeal Membrane Oxygenation (ECMO), Other Cardiac Assist Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=1972&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Cardiovascular Devices Market?# Market?

North America was the largest region in the global cardiovascular devices market in 2024. Western Europe was the second largest region in the global cardiovascular devices market. Africa. was the smallest region in the global cardiovascular devices market. The regions covered in the cardiovascular devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Which Technological Trends Are Reshaping the Cardiovascular Devices Industry Dynamics?

Prominent entities in the cardiovascular devices market are introducing new innovative products such as the balloon ablation catheter, to enhance their market profitability. In the realm of catheter-based cardiac electrophysiological mapping, including both stimulation and recording of the atria, the balloon ablation catheter stands out as the first radiofrequency of its kind. In this regard, Biosense Webster, a US-based firm specializing in the science of diagnosing and treating heart rhythm disorders, launched the HELIOSTAR Balloon Ablation Catheter in October 2022. This cutting-edge product comes with unique one-shot balloon technology that enables pulmonary vein isolation in a mere 12 seconds, accompanied by customised energy delivery and a consolidated 3D mapping solution.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

What Parameters Are Used to Define the Cardiovascular Devices Market?

Cardiovascular devices are used to monitor and control irregular heartbeats and heart rhythm disorders.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=1972

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Cardiovascular Devices Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The market size for cardiovascular devices has seen substantial growth in the past few years. The market, which is currently valued at $67.89 billion in 2024, is expected to rise to $72.22 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.4%. The considerable growth in the previous period is due to factors such as lifestyle-related illnesses, an increasingly aging population, the popularity of minimally invasive procedures and implantable devices, access to healthcare, and regulatory approvals.

Expectations are high for the cardiovascular devices market in the coming years, with strong growth projected. The market is predicted to reach a value of $93.49 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.7%. This growth during the forecast period is linked to developments in personalized medicine, remote monitoring, growth in emerging markets, integration of artificial intelligence (AI), and value-based healthcare. The forecast period also indicates trends such as wearable cardiovascular devices, minimally invasive interventions, bioresorbable devices, remote consultations and telesurgery, along with sustainable and eco-friendly devices.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=1972&type=smp

Which Primay Drivers Are Accelerating Growth in the Cardiovascular Devices Market?

The cardiovascular device market’s growth is fueled in part by the rising incidents of cardiovascular disorders. These disorders pertain to collective medical conditions that impact the heart and blood vessels, including a range of diseases and conditions affecting the circulatory system. Cardiovascular devices are those used to sustain heart performance and blood circulation in individuals with weakened or failing hearts. For example, in June 2023, the Immigration and Checkpoints Authority, a Singapore-based government entity, reported 6,884 deaths resulting from heart and hypertensive diseases in 2022. This represented a 10.35% increase from the 6,238 deaths recorded in 2021. As such, the escalating frequency of cardiovascular disorders is anticipated to propel the expansion of the cardiovascular device market.

Which Primary Segments of the Cardiovascular Devices Market Are Driving Growth and Industry Transformations?

The cardiovascular devicesmarket covered in this report is segmented –

1) By Type: Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment

2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

3) By Type of Expenditure: Public, Private

4) By Product: Instruments Or Equipment, Disposables

Subsegments:

1) By Cardiovascular Surgery Devices And Equipment: Coronary Artery Bypass Graft (CABG) Equipment, Heart Valve Repair And Replacement Devices, Aortic Aneurysm Repair Devices, Cardiopulmonary Bypass Equipment, Other Cardiovascular Surgery Devices

2) By Cardiac Rhythm Management (CRM) Devices And Equipment: Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) Devices

3) By Interventional Cardiology Devices And Equipment: Stents (Drug-Eluting, Bare-Metal), Catheters (Balloon, Diagnostic, Guiding), Angioplasty Equipment, Guidewires, Other Interventional Cardiology Devices

4) By Defibrillator Devices And Equipment: Implantable Cardioverter Defibrillators (ICDs), Automated External Defibrillators (AEDs), Wearable Defibrillators, External Defibrillators

5) By Peripheral Vascular Devices And Equipment: Peripheral Stents, Balloons (Peripheral Angioplasty), Embolic Protection Devices, Endovenous Laser Devices, Other Peripheral Vascular Devices

6) By Prosthetic Heart Valve Devices And Equipment: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves (TAVR), Other Prosthetic Heart Valve Devices

7) By Electrophysiology Devices And Equipment: Ablation Catheters, Electrophysiology Mapping Systems, ECG And EKG Systems, Cardiac Mapping And Navigation Systems, Other Electrophysiology Devices

8) By Cardiac Assist Devices And Equipment: Ventricular Assist Devices (LVADs), Intra-Aortic Balloon Pumps, Total Artificial Heart, Extracorporeal Membrane Oxygenation (ECMO), Other Cardiac Assist Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=1972&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Cardiovascular Devices Market?# Market?

North America was the largest region in the global cardiovascular devices market in 2024. Western Europe was the second largest region in the global cardiovascular devices market. Africa. was the smallest region in the global cardiovascular devices market. The regions covered in the cardiovascular devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Which Technological Trends Are Reshaping the Cardiovascular Devices Industry Dynamics?

Prominent entities in the cardiovascular devices market are introducing new innovative products such as the balloon ablation catheter, to enhance their market profitability. In the realm of catheter-based cardiac electrophysiological mapping, including both stimulation and recording of the atria, the balloon ablation catheter stands out as the first radiofrequency of its kind. In this regard, Biosense Webster, a US-based firm specializing in the science of diagnosing and treating heart rhythm disorders, launched the HELIOSTAR Balloon Ablation Catheter in October 2022. This cutting-edge product comes with unique one-shot balloon technology that enables pulmonary vein isolation in a mere 12 seconds, accompanied by customised energy delivery and a consolidated 3D mapping solution.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

What Parameters Are Used to Define the Cardiovascular Devices Market?

Cardiovascular devices are used to monitor and control irregular heartbeats and heart rhythm disorders.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=1972

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model